SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX: 1777)
Taiwan
· Delayed Price · Currency is TWD 95.10
-0.50 (-0.52%)
Oct 11, 2024, 11:03 AM CST
SYN-TECH Chem. & Pharm. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,215 | 1,115 | 986.3 | 893.23 | 983.79 | 946.41 | Upgrade
|
| Revenue Growth (YoY) | 16.58% | 13.02% | 10.42% | -9.20% | 3.95% | 20.59% | Upgrade
|
| Cost of Revenue | 757.53 | 705.17 | 618.3 | 601.88 | 612.88 | 641.39 | Upgrade
|
| Gross Profit | 457.55 | 409.52 | 368 | 291.35 | 370.91 | 305.02 | Upgrade
|
| Selling, General & Admin | 91.31 | 89.73 | 89.91 | 86.29 | 81.92 | 77.58 | Upgrade
|
| Research & Development | 41.77 | 37.91 | 39.86 | 36.48 | 26.62 | 26.83 | Upgrade
|
| Operating Expenses | 133.08 | 127.67 | 129.77 | 122.77 | 108.54 | 104.41 | Upgrade
|
| Operating Income | 324.47 | 281.85 | 238.23 | 168.59 | 262.37 | 200.61 | Upgrade
|
| Interest Expense | -4.9 | -5.74 | -5.92 | -3.39 | -3.5 | -5.39 | Upgrade
|
| Interest & Investment Income | 28.47 | 29.73 | 16.01 | 2.26 | 6.22 | 15.03 | Upgrade
|
| Earnings From Equity Investments | 0.01 | 0.7 | -11.59 | -0.73 | -3.19 | 2.65 | Upgrade
|
| Currency Exchange Gain (Loss) | 27.68 | 2.57 | 89.96 | -18.79 | -31.27 | -12.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.73 | 5.42 | 34.99 | 119.22 | 1.29 | 2.32 | Upgrade
|
| EBT Excluding Unusual Items | 384.46 | 314.53 | 361.68 | 267.15 | 231.92 | 202.84 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.18 | - | -6.15 | - | 0.99 | 0.18 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.38 | -0.77 | -0.3 | -0.73 | - | -0.1 | Upgrade
|
| Other Unusual Items | - | - | - | -237.39 | - | - | Upgrade
|
| Pretax Income | 382.9 | 313.77 | 355.24 | 200.23 | 232.91 | 202.92 | Upgrade
|
| Income Tax Expense | 78.96 | 62.76 | 59.95 | 23.07 | 46.17 | 43.45 | Upgrade
|
| Net Income | 303.94 | 251.01 | 295.29 | 177.16 | 186.74 | 159.47 | Upgrade
|
| Net Income to Common | 303.94 | 251.01 | 295.29 | 177.16 | 186.74 | 159.47 | Upgrade
|
| Net Income Growth | 12.70% | -14.99% | 66.68% | -5.13% | 17.10% | 3.56% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 35 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 35 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | 0.04% | 0.05% | 26.57% | 17.18% | 0.07% | 0.01% | Upgrade
|
| EPS (Basic) | 6.82 | 5.63 | 6.62 | 5.03 | 6.21 | 5.31 | Upgrade
|
| EPS (Diluted) | 6.81 | 5.62 | 6.61 | 5.02 | 6.20 | 5.30 | Upgrade
|
| EPS Growth | 12.91% | -14.98% | 31.67% | -19.03% | 16.98% | 3.52% | Upgrade
|
| Free Cash Flow | 46.13 | -175.05 | -38.59 | 24.93 | 257.63 | 169.9 | Upgrade
|
| Free Cash Flow Per Share | 1.03 | -3.92 | -0.86 | 0.71 | 8.56 | 5.65 | Upgrade
|
| Dividend Per Share | 3.500 | 3.500 | 3.000 | 2.150 | 4.000 | 3.500 | Upgrade
|
| Dividend Growth | 16.67% | 16.67% | 39.53% | -46.25% | 14.29% | 6.06% | Upgrade
|
| Gross Margin | 37.66% | 36.74% | 37.31% | 32.62% | 37.70% | 32.23% | Upgrade
|
| Operating Margin | 26.70% | 25.29% | 24.15% | 18.87% | 26.67% | 21.20% | Upgrade
|
| Profit Margin | 25.01% | 22.52% | 29.94% | 19.83% | 18.98% | 16.85% | Upgrade
|
| Free Cash Flow Margin | 3.80% | -15.70% | -3.91% | 2.79% | 26.19% | 17.95% | Upgrade
|
| EBITDA | 456.44 | 390.36 | 316.24 | 237.6 | 330.7 | 267.74 | Upgrade
|
| EBITDA Margin | 37.56% | 35.02% | 32.06% | 26.60% | 33.62% | 28.29% | Upgrade
|
| D&A For EBITDA | 131.97 | 108.51 | 78.01 | 69.01 | 68.33 | 67.13 | Upgrade
|
| EBIT | 324.47 | 281.85 | 238.23 | 168.59 | 262.37 | 200.61 | Upgrade
|
| EBIT Margin | 26.70% | 25.29% | 24.15% | 18.87% | 26.67% | 21.20% | Upgrade
|
| Effective Tax Rate | 20.62% | 20.00% | 16.88% | 11.52% | 19.82% | 21.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.